ProKidney Corp (NASDAQ: PROK)’s stock price has increased by 336.93% compared to its previous closing price of $0.61. However, the company has seen a 347.56% increase in its stock price over the last five trading sessions. benzinga.com reported 2025-07-08 that ProKidney Corp. PROK stock is trading higher on Tuesday, with a session volume of 39.8 million compared to the average volume of 1.12 million as per data from Benzinga Pro.
Is It Worth Investing in ProKidney Corp (NASDAQ: PROK) Right Now?
Additionally, the 36-month beta value for PROK is 1.37. There are mixed opinions on the stock, with 3 analysts rating it as a “buy”, 0 rating it as “overweight”, 2 rating it as “hold”, and 0 rating it as “sell”.
The public float for PROK is 94.19M and currently, short sellers hold a 17.84% ratio of that float. The average trading volume of PROK on July 08, 2025 was 1.13M shares.
PROK’s Market Performance
PROK stock saw an increase of 347.56% in the past week, with a monthly gain of 236.72% and a quarterly increase of 342.18%. The volatility ratio for the week is 16.53%, and the volatility levels for the last 30 days are 17.05% for ProKidney Corp (PROK). The simple moving average for the last 20 days is 213.73% for PROK stock, with a simple moving average of 95.21% for the last 200 days.
Analysts’ Opinion of PROK
Many brokerage firms have already submitted their reports for PROK stocks, with BofA Securities repeating the rating for PROK by listing it as a “Underperform”. The predicted price for PROK in the upcoming period, according to BofA Securities is $1 based on the research report published on June 30, 2025 of the current year 2025.
Morgan Stanley gave a rating of “Equal-Weight” to PROK, setting the target price at $3 in the report published on March 07th of the previous year.
PROK Trading at 224.11% from the 50-Day Moving Average
After a stumble in the market that brought PROK to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 2.32% of gains for the given period.
Volatility was left at 17.05%, however, over the last 30 days, the volatility rate increased by 16.53%, as shares surge +123.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +120.16% upper at present.
During the last 5 trading sessions, PROK rose by +268.18%, which changed the moving average for the period of 200-days by -8.79% in comparison to the 20-day moving average, which settled at $0.8213. In addition, ProKidney Corp saw 13.73% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at PROK starting from Control Empresarial de Capital, who purchase 387,393 shares at the price of $0.71 back on Apr 22 ’25. After this action, Control Empresarial de Capital now owns 73,842,723 shares of ProKidney Corp, valued at $276,366 using the latest closing price.
Control Empresarial de Capital, the Add’l Rep. Persons-see Ex.99-1 of ProKidney Corp, purchase 25,000 shares at $0.75 during a trade that took place back on Apr 17 ’25, which means that Control Empresarial de Capital is holding 73,455,330 shares at $18,690 based on the most recent closing price.
Stock Fundamentals for PROK
Current profitability levels for the company are sitting at:
- -604.54% for the present operating margin
- 1.0% for the gross margin
The net margin for ProKidney Corp stands at -223.62%. The total capital return value is set at -0.5%.
Based on ProKidney Corp (PROK), the company’s capital structure generated -0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -36.0. The debt to equity ratio resting at -0.0. The interest coverage ratio of the stock is -26426.86.
Currently, EBITDA for the company is -158.49 million with net debt to EBITDA at 0.59. When we switch over and look at the enterprise to sales, we see a ratio of 5207.72. The receivables turnover for the company is 0.17for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.96.
Conclusion
In conclusion, ProKidney Corp (PROK) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
